Â¥
16.24
Oct 9
Business Description
Porton Pharma Solutions Ltd
ISIN : CNE100001S57
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.76 | |||||
Equity-to-Asset | 0.6 | |||||
Debt-to-Equity | 0.37 | |||||
Debt-to-EBITDA | -5.32 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | 2.65 | |||||
Beneish M-Score | -2.29 | |||||
WACC vs ROIC |
Growth Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 20.7 | |||||
3-Year EBITDA Growth Rate | 7 | |||||
3-Year EPS without NRI Growth Rate | -5.2 | |||||
3-Year Book Growth Rate | 19.3 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 97.67 | |||||
9-Day RSI | 93.54 | |||||
14-Day RSI | 88.65 | |||||
6-1 Month Momentum % | -32.53 | |||||
12-1 Month Momentum % | -58.35 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.19 | |||||
Quick Ratio | 1.64 | |||||
Cash Ratio | 1.04 | |||||
Days Inventory | 119.86 | |||||
Days Sales Outstanding | 99.02 | |||||
Days Payable | 154.96 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 3.02 | |||||
3-Year Dividend Growth Rate | 119.9 | |||||
Forward Dividend Yield % | 3.02 | |||||
5-Year Yield-on-Cost % | 82.35 | |||||
3-Year Average Share Buyback Ratio | -0.2 | |||||
Shareholder Yield % | -4.16 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 24.16 | |||||
Operating Margin % | -9.44 | |||||
Net Margin % | -11.7 | |||||
FCF Margin % | -32.78 | |||||
ROE % | -5.48 | |||||
ROA % | -3.4 | |||||
ROIC % | -3.87 | |||||
ROC (Joel Greenblatt) % | -8.4 | |||||
ROCE % | -4.79 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Forward PE Ratio | 19.18 | |||||
Shiller PE Ratio | 21.65 | |||||
PS Ratio | 3.16 | |||||
PB Ratio | 1.66 | |||||
Price-to-Tangible-Book | 1.86 | |||||
EV-to-EBIT | -30.3 | |||||
EV-to-EBITDA | -30.3 | |||||
EV-to-Revenue | 4.15 | |||||
EV-to-FCF | -10.84 | |||||
Price-to-Projected-FCF | 1.41 | |||||
Price-to-Median-PS-Value | 0.56 | |||||
Earnings Yield (Greenblatt) % | -3.3 | |||||
FCF Yield % | -9.92 | |||||
Forward Rate of Return (Yacktman) % | 21.83 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Porton Pharma Solutions Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 2,680.753 | ||
EPS (TTM) (Â¥) | -0.58 | ||
Beta | 1.84 | ||
Volatility % | 60.75 | ||
14-Day RSI | 88.65 | ||
14-Day ATR (Â¥) | 0.923598 | ||
20-Day SMA (Â¥) | 12.5765 | ||
12-1 Month Momentum % | -58.35 | ||
52-Week Range (Â¥) | 10.91 - 32.66 | ||
Shares Outstanding (Mil) | 545.46 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Porton Pharma Solutions Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Porton Pharma Solutions Ltd Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Porton Pharma Solutions Ltd Frequently Asked Questions
What is Porton Pharma Solutions Ltd(SZSE:300363)'s stock price today?
When is next earnings date of Porton Pharma Solutions Ltd(SZSE:300363)?
Does Porton Pharma Solutions Ltd(SZSE:300363) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |